SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-20-004411
Filing Date
2020-12-22
Accepted
2020-12-22 08:32:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT 1 cns_s1a1.htm S-1/A 323662
2 UNDERWRITING AGREEMENT cns_ex0101.htm EX-1.1 295651
3 FORM OF PURCHASE WARRANT cns_ex0405.htm EX-4.5 113766
4 OPINION OF SCHIFF HARDIN LLP cns_ex0501.htm EX-5.1 13827
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cns_ex2301.htm EX-23.1 2427
  Complete submission text file 0001683168-20-004411.txt   750327
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-251530 | Film No.: 201406110
SIC: 2834 Pharmaceutical Preparations